FDA Inspection 1021884 — Penn State Health Holy Spirit Medical Center
The FDA completed an inspection of Penn State Health Holy Spirit Medical Center on July 19, 2017 in Camp Hill, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 19, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Camp Hill, PA (United States)